California governor signs drug pricing transparency law

Reuters, 10 October 2017
Author: Bill Berkrot
“California Governor Jerry Brown on Monday signed state legislation requiring drug companies to report certain price hikes for prescription medicines in a move that could set a model for other states to follow. The law, which aims to provide more transparency around pharmaceutical and biotech company pricing methods for their medicines, requires drug manufacturers to give a 60-day notice if prices are raised more than 16 percent over a two-year period. The law also requires health plans and insurers to file annual reports outlining how drug costs affect healthcare premiums in California.”
Find article here.

Knowles v Pharmacy Council of NSW

Decision date: 25 September 2017
“CIVIL AND ADMINISTRATIVE TRIBUNAL – Occupational Division – Stay – additional principle in NSW – protection of health and safety of the public the paramount consideration. In the January 2017 Decision, the Council found that, given a lack of adherence to accepted guidelines and the lack of substantive evidence about the safety and efficacy of certain drugs in humans, the applicant’s practice in relation to the dispensing of peptides was not within accepted standards nor compliant with the Pharmacy Board of Australia (PBA)’s Guidelines on Compounding Medicines (the PBA Guidelines) or otherwise met the public interest.”
Find decision here.

‘Shocking’ disregard for safety in U.S. meningitis case -prosecutor

Reuters, 21 September 2017
Author: Nate Raymond
“A federal prosecutor on Tuesday accused a Massachusetts pharmacist charged with murder for his role in a deadly 2012 U.S. meningitis outbreak of showing a “shocking” disregard for patients’ lives, while his lawyer argued the man was no killer.”
Find article here.

FDA plans new compounding pharmacy policy, agency head says

Reuters, 16 September 2017
Author: Nate Raymond
“The head of the U.S. Food and Drug Administration said on Friday the agency is working on a new policy that would encourage more compounding pharmacies to register under a law enacted in the wake of a deadly 2012 meningitis outbreak linked to one such company.”
Find article here.

Ten-year ban for steroid-prescribing doctor

Australian Doctor, 27 June 2017
Author: Anthony Scholefield
“A doctor who wrote in his notes “naughty boy wants to get buff by April” when prescribing steroids and stimulants to hundreds of body-builders has been struck off for 10 years.”
Find article here.

A doctor prescribed so many painkillers, she’s been charged with murdering her patients, authorities say

Washington Post, 24 June 2017
Author: Cleve R. Wootson Jr.
“Law enforcement agents aren’t just going after drug dealers and Mexican cartels — they’re also targeting pharmaceutical companies and doctors, who they say are irresponsibly flooding the nation with potent painkillers, and holding them responsible for overdose deaths.”
Find article here.

Medical Board of Australia v Griffiths (Review and Regulation)

Decision date: 9 June 2017
“Review and Regulation List – medical practitioner – inappropriate prescription and medical treatment – prescription of opioids and benzodiazepines – inappropriate treatment of persons with whom shared a close personal relationship – breach of S8 permit obligations – agreed facts and findings and joint proposed determinations – Medical Practice Act 1994 (Vic) s 3(1), Health Professions Registration Act 2005 (Vic) s 3(1), Health Practitioner Regulation National Law (Victoria) Act 2009 (Vic) s 5(a).”
Find order here.

Health Care Complaints Commission v West [2017] NSWCATOD 39

Decision date: 22 March 2017
“MEDICAL PRACTITIONER – inappropriate prescription of drugs of addiction – inadequate clinical records – admissions by respondent. Held- respondent guilty of professional misconduct -orders made cancelling registration and for payment of costs.”
Find decision here.

WHO Launches Global Effort to Halve Medication-Related Errors in 5 Years

WHO, 29 March 2017
“WHO today launched a global initiative to reduce severe, avoidable medication-associated harm in all countries by 50% over the next 5 years. The Global Patient Safety Challenge on Medication Safety aims to address the weaknesses in health systems that lead to medication errors and the severe harm that results. It lays out ways to improve the way medicines are prescribed, distributed and consumed, and increase awareness among patients about the risks associated with the improper use of medication.”
Find news release here.

EU recommends suspending hundreds of drugs tested by Indian firm

Reuters, 25 March 2017
Author: Ben Hirschler
“Europe’s medicines regulator has recommended the suspension of more than 300 generic drug approvals and drug applications due to “unreliable” tests conducted by Indian contract research firm Micro Therapeutic Research Labs.”
Find article here.